ADAR1 Capital Management’s Regenxbio RGNX Stock Holding History

ADAR1 Capital Management’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$372K	Sell	44,416 -100,432	-69%	-$1.06M	0.02%	224
2025 Q4	$2.09M	Sell	144,848 -60,561	-29%	-$755K	0.15%	97
2025 Q3	$1.98M	Sell	205,409 -2,409	-1%	-$21.3K	0.19%	79
2025 Q2	$1.71M	Sell	207,818 -142,534	-41%	-$1.19M	0.26%	61
2025 Q1	$2.51M	Buy	350,352 +180,223	+106%	+$1.34M	0.47%	53
2024 Q4	$1.32M	Sell	170,129 -398,879	-70%	-$3.75M	0.26%	66
2024 Q3	$5.97M	Buy	569,008 +566,308	+20,974%	+$6.9M	0.97%	24
2024 Q2	$31.6K	Buy	2,700 +200	+8%	+$3.11K	0.01%	204
2024 Q1	$52.7K	Buy	+2,500	New	+$44.5K	0.01%	176

Other funds holding RGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return